SARS-CoV-2 Spike S1 Proteine
| Catalog no. | Produkt | Reaktivität | Wirt / Klonalität | Anwendung | Preis & Lieferzeit |
|---|---|---|---|---|---|
| SARS-CoV-2 Spike S1 Protein (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
580,80 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-683, B.1.1.529 - Omicron) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
380,58 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-683, BA.2.12.1 - Omicron) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
425,65 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-683, BA.4 - Omicron, BA.5 - Omicron, BA.5.2 - Omicron) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
413,64 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-683, C.37 - Lambda) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
413,64 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-667) (hFc-Avi Tag) | SARS Coronavirus (SARS-CoV) | HEK-293 Cells |
|
380,58 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 16-685, E484K, K417N, N501Y) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
425,65 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-683, B.1.1.529 - Omicron) (Biotin,His-Avi Tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
628,47 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-683, D614G) (His-Avi Tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
413,64 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-683, B.1.617.2 - delta) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
425,65 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-683, P.1 - gamma, P.1.1 - Gamma, P.1.2 - Gamma) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
425,65 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 16-685, N501Y) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
380,58 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (RBD) (His tag,AVI tag,Biotin) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
2.574,00 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (His tag,Fc Tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
330,00 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (His-Avi Tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
415,00 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (RBD) (mFc Tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
325,00 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 13-303, N-Term) (mFc Tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
893,85 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 13-303, N-Term) (Fc Tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
872,31 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-683, B.1.640.2) (His tag) | SARS Coronavirus-2 (SARS-CoV-2) | HEK-293 Cells |
|
380,58 €
Preis anzeigen
|
|
| SARS-CoV-2 Spike S1 Protein (AA 14-667) (hFc-Avi Tag,Biotin) | SARS Coronavirus (SARS-CoV) | HEK-293 Cells |
|
628,47 €
Preis anzeigen
|
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- SPR (Surface Plasmon Resonance: Validierungsbild verfügbar)
- BLI (Bio-Layer Interferometry: Validierungsbild verfügbar)
- Func (Functional Studies: Angegebene Anwendung)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- >90 % as determined by SDS-PAGE.
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus (SARS-CoV)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 90 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 90 % as determined by SDS-PAGE. > 90 % as determined by SEC-MALS.
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Func (Functional Studies: Angegebene Anwendung)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 90 % by SDS-PAGE.
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Func (Functional Studies: Angegebene Anwendung)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- >95 % by SDS-PAGE,> 95 % by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- Func (Functional Studies: Angegebene Anwendung)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % by SDS-PAGE.
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- AM (Affinity Measurement: Angegebene Anwendung)
- ADA (Antibody Drug Assay: Angegebene Anwendung)
- IA (Immunoassay: Angegebene Anwendung)
- ScA (Screening Assay: Angegebene Anwendung)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- ELISA (ELISA: Validierungsbild verfügbar)
- AM (Affinity Measurement: Angegebene Anwendung)
- ADA (Antibody Drug Assay: Angegebene Anwendung)
- IA (Immunoassay: Angegebene Anwendung)
- ScA (Screening Assay: Angegebene Anwendung)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus-2 (SARS-CoV-2)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
- SDS (SDS-PAGE: Validierungsbild verfügbar)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: Validierungsbild verfügbar)
- Spezies
- SARS Coronavirus (SARS-CoV)
- Wirt
- HEK-293 Cells
- Protein-Typ
- Recombinant
- Reinheit
- > 95 % as determined by Bis-Tris PAGE,> 95 % as determined by HPLC
- Biologische Aktivität
- Active
Aktuelle Publikationen für unsere SARS-CoV-2 Spike S1 Proteine
: "Point-of-care (POC) SARS-CoV-2 antigen detection using functionalized aerosol jet-printed organic electrochemical transistors (OECTs)." in: Nanoscale, Vol. 15, Issue 11, pp. 5476-5485, (2023) (PubMed).
: "Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection." in: Stroke, Vol. 52, Issue 1, pp. 260-270, (2021) (PubMed).
: "Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Issue 5, (2021) (PubMed).
: "SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus." in: Communications biology, Vol. 4, Issue 1, pp. 129, (2021) (PubMed).
: "Protein Footprinting, Conformational Dynamics, and Core Interface-Adjacent Neutralization "Hotspots" in the SARS-CoV-2 Spike Protein Receptor Binding Domain/Human ACE2 Interaction." in: Journal of the American Society for Mass Spectrometry, (2021) (PubMed).
: "Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum." in: ACS infectious diseases, (2021) (PubMed).
: "Delayed production of neutralizing antibodies correlates with fatal COVID-19. ..." in: Nature medicine, (2021) (PubMed).
: "Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. ..." in: Cell reports. Medicine, pp. 100288, (2021) (PubMed).
: "A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes. ..." in: Nature communications, Vol. 12, Issue 1, pp. 2623, (2021) (PubMed).
Aliase für SARS-CoV-2 Spike S1 Proteine
Surface Glycoprotein (S) ProteineE2 Proteine
Haben Sie etwas anderes gesucht?
- SARS-CoV-2 Spike Proteine
- SARS-CoV-2 Papain-Like Protease Proteine
- SARS-CoV-2 Nucleocapsid Proteine
- SARS-CoV-2 NSP5 (3CL-Pro) Proteine
- SARS-CoV-2 Non-Structural Protein 7 Proteine
- SARS-CoV Spike Proteine
- SARS-Coronavirus Nucleocapsid Protein Proteine
- SARS-Coronavirus Membrane Protein Proteine
- SARNP Proteine
- SARM1 Proteine
- SARDH Proteine
- Sarcolemma Associated Protein Proteine
- Sarcalumenin Proteine
- SAR1B Proteine
- SAR1A Proteine
- SAPS2 Proteine
- SAPS1 Proteine
- SAP30BP Proteine
- SAP30-Like Proteine
- SAP30 Proteine
- SARS-CoV-2 Spike S2 Proteine
- SARS2 Proteine
- SART1 Proteine
- SART3 Proteine
- SASH1 Proteine
- SASH3 Proteine
- SAT1 Proteine
- SAT2 Proteine
- SATB1 Proteine
- SATB2 Proteine
- SAV1 Proteine
- SBDS Proteine
- SBEM Proteine
- SBK1 Proteine
- SBNO1 Proteine
- SC4MOL Proteine
- SC5DL Proteine
- SCAMP1 Proteine
- SCAMP3 Proteine
- SCAND1 Proteine